Veterinary Medicines

CEVAC ND-IB-EDS K

Authorised
  • Newcastle disease virus, strain La Sota, Live
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Eggdrop syndrome-1976 virus, strain B8/78, Inactivated
Download as PDF

Product identification

Medicine name:
СЕВАК НД-ИБ-ЕДС К
CEVAC ND-IB-EDS K
Active substance:
  • Newcastle disease virus, strain La Sota, Live
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Eggdrop syndrome-1976 virus, strain B8/78, Inactivated
Target species:
  • Chicken (hen)
  • Chicken (chick)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Newcastle disease virus, strain La Sota, Live
    4.00
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    6.00
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Eggdrop syndrome-1976 virus, strain B8/78, Inactivated
    7.00
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (hen)
  • Subcutaneous use
    • Chicken (chick)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA13
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Veterinary Biologicals Co. Ltd
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-1616-22.08.2011
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 20/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."